URGN vs VKTX Stock Comparison

URGN currently leads VKTX in this stock comparison, with AIQ scores of 53 vs 41. The clearest difference is quality, while VKTX has the stronger momentum profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 12 points
URGN
Healthcare
vs
VKTX
Healthcare
URGN
UroGen Pharma Ltd.
Leads
Price
$26.18
Day move
-0.8%
AIQ Score
53/100
Best edge
Quality
Sector
Healthcare
VKTX
Viking Therapeutics, Inc.
Price
$29.22
Day move
+5.95%
AIQ Score
41/100
Best edge
Momentum
Sector
Healthcare

What is the main difference between URGN and VKTX?

URGN leads the current stock comparison as UroGen Pharma Ltd., with the clearest separation coming from quality and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

UroGen Pharma Ltd. vs Viking Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 5/10

URGN leads

URGN leads by 12 AIQ points, primarily on Quality, but the lead has narrowed from 28 points over 30 sessions. Wall Street currently favors VKTX on target upside.

Fragile: 2 of 5 evidence groups support URGN, its lead is narrowing, and its current signal state is conflicted.

Evidence agreement: 2 of 5Comparison trend: Weakening
URGN

UroGen Pharma Ltd.

Leads
AIQ Score
53/100
AIQ Edge Score
5/10
VKTX

Viking Therapeutics, Inc.

AIQ Score
41/100
AIQ Edge Score
7/10

The Algovestiq AIQ Score currently favors URGN over VKTX, 53 versus 41 as of Nov 15, 2026. URGN's advantage is driven primarily by stronger quality, while VKTX holds the stronger momentum profile. URGN also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors VKTX. 2 of 5 covered evidence groups favor URGN today, and the comparison is rated Fragile on stability: only 2 of 5 covered evidence groups agree. URGN lead: Weakening — the AIQ differential moved from 28 to 12 points over 30 sessions.

Compare UroGen Pharma Ltd. and Viking Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

URGN
+100.5%
VKTX
+404.7%

Price return comparison

Growth of $10,000, price only

URGN $20,046 · VKTX $50,466

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare URGN and VKTX against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

URGN advantage
0
VKTX advantage
  • Quality68 vs 33
    URGN +35
  • Momentum40 vs 47
    VKTX +7
  • Risk Resilience40 vs 41
    Even

2 of 5 evidence groups favor URGN. URGN’s edge is concentrated in quality; VKTX keeps a meaningful momentum edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

URGN0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 5 active signals are unchanged.

VKTX+2 AIQ

Largest factor move: Momentum +3

New signals

  • Accumulation Pattern — bullish, volume, medium horizon (2.11x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon

URGN's lead narrowed by 2 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — URGN and VKTX both carry a full feed there.

The central trade-off

URGN (UroGen Pharma Ltd.): the stronger current systematic profile, led by quality.

VKTX (Viking Therapeutics, Inc.): the counter-case, on momentum, technicals, analyst expectations.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

URGN

URGN on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

URGN

URGN on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

VKTX

VKTX on the Momentum factor, by 7 points.

Lower downside

VKTX

VKTX carries the lower 1-month annualized volatility.

Analyst upside

VKTX

VKTX on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors URGN, analyst targets favor VKTX. That disagreement is the most useful thing on this page.

MeasureURGNVKTXNote
Implied upside to target+121.5%+172.6%VKTX has more room
Target dispersion+6.9%+107.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering821Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

2 of 5 covered evidence groups favor URGN. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreURGN53 vs 41
FundamentalsURGNEPS growth 89.3% vs -40.9%; TTM ROE 1.2% vs -31.1%
ValuationNot coveredNot covered
TechnicalsVKTXPrice vs 50-day -29.2% vs -0.4%; vs 200-day -17.4% vs -9.2%
Risk ResilienceEvenRisk Resilience 40 vs 41
Analyst expectationsVKTXTarget upside 121.5% vs 172.6%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of URGN and VKTX and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is wide at 12 points. (supports the conclusion holding)
  • Only 2 of 5 covered evidence groups agree. (argues the conclusion is provisional)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on URGN.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

URGN lead: Weakening — the AIQ differential moved from 28 to 12 points over 30 sessions.

May 27URGN leads above the line · VKTX leads belowNov 13
Today
URGN +12
53 vs 41
7 sessions ago
URGN +18
57 vs 39
30 sessions ago
URGN +28
63 vs 35
90 sessions ago
URGN +21
70 vs 49

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

URGNConflicted

2 bullish / 1 bearish / 2 neutral, conflicted

Only URGN

  • Golden Cross Active — bullish, trend, long horizon (16.77%)
  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Keltner Channel Breakdown — bearish, volatility, short horizon
  • RSI Oversold — bullish, momentum, short horizon
VKTXConflicted

4 bullish / 3 bearish / 1 neutral, conflicted

Only VKTX

  • Death Cross Active — bearish, trend, long horizon (9.70%)
  • Accumulation Pattern — bullish, volume, medium horizon (2.11x)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • Downtrend Structure Active — bearish, trend, long horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • RSI Midline Reclaim — bullish, momentum, short horizon
  • Volume Surge - Bullish — bullish, volume, short horizon (2.11x)

Both carry 1 more signal that do not separate them: ATR Expansion - Breakout Mode.

URGN leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

URGNNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.8%, AIQ 0 points).

VKTXConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +5.95%, AIQ +2 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1VKTX closes the Quality gap — currently 35 points behind, the largest single contributor to URGN's edge.
  2. 2VKTX's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once.
  4. 4The narrowing continues — the lead has already given back 16 points over 30 sessions, and a further 12-point move would eliminate URGN's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

URGN leads on balance
MetricURGNVKTX
Revenue growth (YoY)22.8%0%
EPS growth (YoY)89.3%-40.9%
Gross margin91.4%0%
Operating margin-12.4%0%
Return on equity (TTM)1.2%-31.1%
Debt to equity-1.570.43

Performance

VKTX leads 4 of 6 windows
MetricURGNVKTX
1 week (5 sessions)5.8%8.9%
1 month (20 sessions)-24.2%16.1%
3 months (63 sessions)-46.7%-13.1%
6 months (126 sessions)-9%-3.5%
Year to date11.8%-16.9%
1 year (252 sessions)4.1%-28.3%

Technicals

VKTX has the stronger structure
MetricURGNVKTX
RSI (14)28.755
ADX (14)45.113.7
Price vs 50-day-29.2%-0.4%
Price vs 200-day-17.4%-9.2%
Volatility (1M, annualized)79.4%69.7%

Risk

Split
MetricURGNVKTX
Beta1.331.29
Sharpe ratio0.39-0.15
Sortino ratio0.56-0.25
Max drawdown-50.8%-42.5%
Current drawdown-47.9%-30.6%
Annualized volatility61.9%69.2%
Value at risk (95%)-5.5%-5.6%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, URGN or VKTX?

On the Algovestiq AIQ Score, URGN is the stronger of the two as of Nov 15, 2026, scoring 53 against VKTX's 41. The edge comes from quality. VKTX is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is URGN or VKTX the better buy right now?

URGN carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 2 of 5 covered evidence groups agree. Treat the lead as provisional.

Why does the AIQ Score favor URGN over VKTX?

The composite weights Quality, Value, Momentum and Risk Resilience. URGN leads Quality by 35 points; VKTX leads Momentum by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, URGN or VKTX?

Analyst price targets imply +121.5% upside for URGN and +172.6% for VKTX, so the Street currently favors VKTX. That points the opposite way to the AIQ Score, which favors URGN. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, URGN or VKTX?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, URGN or VKTX?

URGN on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, URGN or VKTX?

VKTX on the Momentum factor, by 7 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, URGN or VKTX?

VKTX is the more resilient of the two, so the other name carries the higher downside risk. VKTX carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is URGN more profitable than VKTX?

URGN leads on the comparable margin measures — gross margin 91.4% vs 0%; operating margin -12.4% vs 0%; ttm roe 1.2% vs -31.1%.

Is URGN's lead over VKTX getting stronger or weaker?

URGN lead: Weakening — the AIQ differential moved from 28 to 12 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the URGN vs VKTX verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: VKTX closes the Quality gap — currently 35 points behind, the largest single contributor to URGN's edge; VKTX's Death Cross Active resolves — a bearish trend rule currently active against it; URGN's conflicting signal state resolves bearish — it currently carries 2 bullish and 1 bearish rules at once; the narrowing continues — the lead has already given back 16 points over 30 sessions, and a further 12-point move would eliminate URGN's advantage entirely.

What do the current signals say about URGN and VKTX?

URGN: 2 bullish / 1 bearish / 2 neutral, conflicted. VKTX: 4 bullish / 3 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on URGN is Golden Cross Active (bullish, long horizon). On VKTX it is Death Cross Active (bearish, long horizon).

Compare URGN and VKTX with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.